Avanos Medical Inc
(AVNS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 697,600 | 652,300 | 611,600 | 566,200 | 509,000 |
| Cost of Goods | 295,400 | 261,400 | 274,700 | 269,000 | 251,200 |
| Gross Profit | 402,200 | 390,900 | 336,900 | 297,200 | 257,800 |
| Operating Expenses | 458,300 | 390,800 | 380,700 | 404,300 | 393,700 |
| Operating Income | -55,700 | 500 | -43,100 | -107,100 | -135,700 |
| Interest Expense | 15,000 | 26,400 | 31,600 | 32,700 | 33,100 |
| Other Income | 6,700 | 7,800 | 2,500 | 600 | 300 |
| Pre-tax Income | -64,000 | -18,100 | -72,200 | -139,200 | -168,500 |
| Income Tax | -18,100 | -9,600 | -40,100 | -55,900 | -67,300 |
| Net Income Continuous | -45,900 | -8,500 | -32,100 | -83,300 | -101,200 |
| Net Income Discontinuous | N/A | 66,000 | 111,400 | 123,100 | -325,100 |
| Net Income | $-45,900 | $57,500 | $79,300 | $39,800 | $-426,300 |
| EPS Basic Total Ops | -0.96 | 1.22 | 1.69 | 0.85 | -9.15 |
| EPS Basic Continuous Ops | -0.96 | -0.18 | -0.69 | -1.79 | -2.17 |
| EPS Basic Discontinuous Ops | N/A | 1.40 | 2.38 | 2.64 | -6.98 |
| EPS Diluted Total Ops | -0.96 | 1.22 | 1.69 | 0.85 | -9.15 |
| EPS Diluted Continuous Ops | -0.96 | -0.18 | -0.69 | -1.79 | -2.17 |
| EPS Diluted Discontinuous Ops | N/A | 1.40 | 2.38 | 2.64 | -6.98 |
| EPS Diluted Before Non-Recurring Items | 1.07 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-18,800 | $34,000 | $16,400 | $-41,900 | $403,700 |